Market Research Heavy Industry Market Research Materials & Chemicals Market Research Plastics Market Research Polymers Market Research

HPMC Capsules

Best Price Guarantee Length Publisher Published Date SKU
from $4,950 177 Pages Global Industry Analysts April, 2021 GJOB16577830
Best Price Guarantee
Price from $4,950
Length 177 Pages
Publisher Global Industry Analysts
Published Date April, 2021
SKU GJOB16577830

HPMC Capsules

Global Hydroxypropyl Methylcellulose (HPMC) Capsules Market to Reach $672.3 Million by 2027

Amid the COVID-19 crisis, the global market for Hydroxypropyl Methylcellulose (HPMC) Capsules estimated at US$356.7 Million in the year 2020, is projected to reach a revised size of US$672.3 Million by 2027, growing at aCAGR of 9.5% over the period 2020-2027. With Gelling Aid, one of the segments analyzed in the report, is projected to record 9% CAGR and reach US$432.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Without Gelling Aid segment is readjusted to a revised 10.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $105.7 Million, While China is Forecast to Grow at 8.9% CAGR

The Hydroxypropyl Methylcellulose (HPMC) Capsules market in the U.S. is estimated at US$105.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$116.7 Million by the year 2027 trailing a CAGR of 8.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.7% and 7.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Select Competitors (Total 42 Featured) -

  • ACG Worldwide Pvt., Ltd.
  • BioCaps Enterprise
  • Bright Caps GmbH
  • Bright Pharmacaps Inc.
  • Capscanada Corporation
  • Capsugel, Inc.
  • Excellent Health Products Co., Ltd.
  • Farmacapsulas S.A.
  • Healthcaps India Limited
  • Natural Capsules Ltd.
  • Qualicaps, Inc.
  • Shanghai Honest Chem Co., Ltd.
  • Shaoxing Kangke Capsule Co., Ltd.
  • Suheung Co Ltd.
  • Sunil Healthcare
  • Wuhan Carma Technology Co., Ltd
  • Zhejiang Yuexi Capsule Co., Ltd.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Current & Future Analysis for HPMC Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for HPMC Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for HPMC Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
TABLE 4: World Current & Future Analysis for With Gelling Aid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for With Gelling Aid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for With Gelling Aid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 7: World Current & Future Analysis for Without Gelling Aid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Without Gelling Aid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Without Gelling Aid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 10: World Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 13: World Current & Future Analysis for CMOs (Contract Manufacturing Organizations) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for CMOs (Contract Manufacturing Organizations) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for CMOs (Contract Manufacturing Organizations) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 16: World Current & Future Analysis for Food and Beverage Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Food and Beverage Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Food and Beverage Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 19: World Current & Future Analysis for Cosmetic Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Cosmetic Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Cosmetic Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
TABLE 22: USA Current & Future Analysis for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 23: USA Historic Review for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: USA 15-Year Perspective for HPMC Capsules by Product Type - Percentage Breakdown of Value Sales for With Gelling Aid and Without Gelling Aid for the Years 2012, 2020 & 2027
TABLE 25: USA Current & Future Analysis for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 26: USA Historic Review for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: USA 15-Year Perspective for HPMC Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies for the Years 2012, 2020 & 2027
CANADA
TABLE 28: Canada Current & Future Analysis for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 29: Canada Historic Review for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: Canada 15-Year Perspective for HPMC Capsules by Product Type - Percentage Breakdown of Value Sales for With Gelling Aid and Without Gelling Aid for the Years 2012, 2020 & 2027
TABLE 31: Canada Current & Future Analysis for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 32: Canada Historic Review for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: Canada 15-Year Perspective for HPMC Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies for the Years 2012, 2020 & 2027
JAPAN
TABLE 34: Japan Current & Future Analysis for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 35: Japan Historic Review for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: Japan 15-Year Perspective for HPMC Capsules by Product Type - Percentage Breakdown of Value Sales for With Gelling Aid and Without Gelling Aid for the Years 2012, 2020 & 2027
TABLE 37: Japan Current & Future Analysis for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 38: Japan Historic Review for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: Japan 15-Year Perspective for HPMC Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies for the Years 2012, 2020 & 2027
CHINA
TABLE 40: China Current & Future Analysis for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: China Historic Review for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: China 15-Year Perspective for HPMC Capsules by Product Type - Percentage Breakdown of Value Sales for With Gelling Aid and Without Gelling Aid for the Years 2012, 2020 & 2027
TABLE 43: China Current & Future Analysis for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: China Historic Review for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: China 15-Year Perspective for HPMC Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies for the Years 2012, 2020 & 2027
EUROPE
TABLE 46: Europe Current & Future Analysis for HPMC Capsules by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 47: Europe Historic Review for HPMC Capsules by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: Europe 15-Year Perspective for HPMC Capsules by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
TABLE 49: Europe Current & Future Analysis for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 50: Europe Historic Review for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: Europe 15-Year Perspective for HPMC Capsules by Product Type - Percentage Breakdown of Value Sales for With Gelling Aid and Without Gelling Aid for the Years 2012, 2020 & 2027
TABLE 52: Europe Current & Future Analysis for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: Europe Historic Review for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: Europe 15-Year Perspective for HPMC Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies for the Years 2012, 2020 & 2027
FRANCE
TABLE 55: France Current & Future Analysis for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: France Historic Review for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: France 15-Year Perspective for HPMC Capsules by Product Type - Percentage Breakdown of Value Sales for With Gelling Aid and Without Gelling Aid for the Years 2012, 2020 & 2027
TABLE 58: France Current & Future Analysis for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: France Historic Review for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: France 15-Year Perspective for HPMC Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies for the Years 2012, 2020 & 2027
GERMANY
TABLE 61: Germany Current & Future Analysis for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: Germany Historic Review for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: Germany 15-Year Perspective for HPMC Capsules by Product Type - Percentage Breakdown of Value Sales for With Gelling Aid and Without Gelling Aid for the Years 2012, 2020 & 2027
TABLE 64: Germany Current & Future Analysis for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: Germany Historic Review for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: Germany 15-Year Perspective for HPMC Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies for the Years 2012, 2020 & 2027
ITALY
TABLE 67: Italy Current & Future Analysis for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Italy Historic Review for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: Italy 15-Year Perspective for HPMC Capsules by Product Type - Percentage Breakdown of Value Sales for With Gelling Aid and Without Gelling Aid for the Years 2012, 2020 & 2027
TABLE 70: Italy Current & Future Analysis for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Italy Historic Review for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: Italy 15-Year Perspective for HPMC Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies for the Years 2012, 2020 & 2027
UNITED KINGDOM
TABLE 73: UK Current & Future Analysis for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: UK Historic Review for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: UK 15-Year Perspective for HPMC Capsules by Product Type - Percentage Breakdown of Value Sales for With Gelling Aid and Without Gelling Aid for the Years 2012, 2020 & 2027
TABLE 76: UK Current & Future Analysis for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: UK Historic Review for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: UK 15-Year Perspective for HPMC Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies for the Years 2012, 2020 & 2027
REST OF EUROPE
TABLE 79: Rest of Europe Current & Future Analysis for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: Rest of Europe Historic Review for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: Rest of Europe 15-Year Perspective for HPMC Capsules by Product Type - Percentage Breakdown of Value Sales for With Gelling Aid and Without Gelling Aid for the Years 2012, 2020 & 2027
TABLE 82: Rest of Europe Current & Future Analysis for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: Rest of Europe Historic Review for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: Rest of Europe 15-Year Perspective for HPMC Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies for the Years 2012, 2020 & 2027
ASIA-PACIFIC
TABLE 85: Asia-Pacific Current & Future Analysis for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: Asia-Pacific Historic Review for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: Asia-Pacific 15-Year Perspective for HPMC Capsules by Product Type - Percentage Breakdown of Value Sales for With Gelling Aid and Without Gelling Aid for the Years 2012, 2020 & 2027
TABLE 88: Asia-Pacific Current & Future Analysis for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Asia-Pacific Historic Review for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: Asia-Pacific 15-Year Perspective for HPMC Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies for the Years 2012, 2020 & 2027
REST OF WORLD
TABLE 91: Rest of World Current & Future Analysis for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: Rest of World Historic Review for HPMC Capsules by Product Type - With Gelling Aid and Without Gelling Aid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: Rest of World 15-Year Perspective for HPMC Capsules by Product Type - Percentage Breakdown of Value Sales for With Gelling Aid and Without Gelling Aid for the Years 2012, 2020 & 2027
TABLE 94: Rest of World Current & Future Analysis for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Rest of World Historic Review for HPMC Capsules by End-Use - Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: Rest of World 15-Year Perspective for HPMC Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, CMOs (Contract Manufacturing Organizations), Food and Beverage Companies and Cosmetic Companies for the Years 2012, 2020 & 2027
IV. COMPETITION
Total Companies Profiled: 42

$4,950

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings